您的位置: 首页 > 农业专利 > 详情页

PROCEDES EX VIVO POUR MINIMISER LES RISQUES ET MAXIMISER LES EFFETS BENEFIQUES D'UNE TRANSFUSION DE SANG ALLOGENIQUE ET GREFFE DE MOELLE
专利权人:
STEVENS INSTITUTE OF TECHNOLOGY;HACKENSACK UNIVERSITY MEDICAL CENTER
发明人:
ZILBERBERG, JENNY,LEE, WOO,KORNGOLD, ROBERT
申请号:
CA2972846
公开号:
CA2972846A1
申请日:
2016.01.08
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
The described invention provides an ex vivo model of persistent T lymphocyte stimulation events encountered by circulating T lymphocytes at lymph node and tissue levels in vivo; a method for optimizing donor selection for allogeneic blood and marrow transplantation (BMT) therapy; and a method for minimizing risks and maximizing benefits of performing allogeneic blood and marrow transplantation (BMT) therapy in a recipient subject, wherein the recipient subject has a hematologic malignancy.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充